Next Article in Journal
Rationale Efficacy and Safety Evidence of Lenvatinib and Pembrolizumab Association in Anaplastic Thyroid Carcinoma
Next Article in Special Issue
Financial Toxicity and Out-of-Pocket Costs for Patients with Head and Neck Cancer
Previous Article in Journal
Clinical Factors Associated with Long-Term Survival in Metastatic Melanoma Treated with Anti-PD1 Alone or in Combination with Ipilimumab
Previous Article in Special Issue
Patient Perceived Financial Burden in Haematological Malignancies: A Systematic Review
 
 
Article

Article Versions Notes

Curr. Oncol. 2022, 29(10), 7705-7717; https://doi.org/10.3390/curroncol29100609
Action Date Notes Link
article xml file uploaded 14 October 2022 11:55 CEST Original file -
article xml uploaded. 14 October 2022 11:55 CEST Update https://www.mdpi.com/1718-7729/29/10/609/xml
article pdf uploaded. 14 October 2022 11:55 CEST Version of Record https://www.mdpi.com/1718-7729/29/10/609/pdf
article html file updated 14 October 2022 11:56 CEST Original file -
article html file updated 28 February 2023 18:03 CET Update -
article html file updated 1 March 2023 21:37 CET Update https://www.mdpi.com/1718-7729/29/10/609/html
Back to TopTop